These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33997311)

  • 1. Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis - Diabetes co-morbidity.
    Kumar NP; Moideen K; Viswanathan V; Sivakumar S; Hissar S; Kornfeld H; Babu S
    J Clin Tuberc Other Mycobact Dis; 2021 May; 23():100237. PubMed ID: 33997311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment.
    Kumar NP; Moideen K; Viswanathan V; Shruthi BS; Sivakumar S; Menon PA; Kornfeld H; Babu S
    BMC Infect Dis; 2018 Jul; 18(1):345. PubMed ID: 30045688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity.
    Kumar NP; Moideen K; Bhootra Y; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
    Immunology; 2019 Mar; 156(3):249-258. PubMed ID: 30427060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Hissar S; Kornfeld H; Babu S
    BMC Infect Dis; 2019 Dec; 19(1):1039. PubMed ID: 31818258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidity.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
    Cytokine; 2020 Jan; 125():154824. PubMed ID: 31472402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden.
    Pavan Kumar N; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Shanmugam S; Hissar S; Kornfeld H; Babu S
    Front Cell Infect Microbiol; 2019; 9():335. PubMed ID: 31632923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Are Potential Biomarkers of Pulmonary and Extra-Pulmonary Tuberculosis.
    Kathamuthu GR; Kumar NP; Moideen K; Nair D; Banurekha VV; Sridhar R; Baskaran D; Babu S
    Front Immunol; 2020; 11():419. PubMed ID: 32218787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
    Kumar NP; Moideen K; Sivakumar S; Menon PA; Viswanathan V; Kornfeld H; Babu S
    J Infect; 2017 Jan; 74(1):10-21. PubMed ID: 27717783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of INF-γ as an immunological healing marker based on anti-tubercular treatment among diabetic and non-diabetic pulmonary tuberculosis patients.
    Yadav BK; Shah AK; Karunanand B; Sudan DS; Sharma M
    Horm Mol Biol Clin Investig; 2023 Mar; 44(1):33-37. PubMed ID: 36148507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort Study.
    Gil-Santana L; Almeida-Junior JL; Oliveira CA; Hickson LS; Daltro C; Castro S; Kornfeld H; Netto EM; Andrade BB
    PLoS One; 2016; 11(1):e0146876. PubMed ID: 26752596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment.
    Kumar NP; Moideen K; Sivakumar S; Menon PA; Viswanathan V; Kornfeld H; Babu S
    Tuberculosis (Edinb); 2016 Dec; 101():191-200. PubMed ID: 27865391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus.
    Lee YJ; Han SK; Park JH; Lee JK; Kim DK; Chung HS; Heo EY
    Korean J Intern Med; 2018 Sep; 33(5):933-940. PubMed ID: 29540054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
    Heo E; Kim E; Jang EJ; Lee CH
    BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features in pulmonary tuberculosis patients combined with diabetes mellitus in China: An observational study.
    Tong X; Wang D; Wang H; Liao Y; Song Y; Li Y; Zhang Y; Fan G; Zhong X; Ju Y; Li Y
    Clin Respir J; 2021 Sep; 15(9):1012-1018. PubMed ID: 34087059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment.
    Kumar NP; Moideen K; Viswanathan V; Sivakumar S; Menon PA; Kornfeld H; Babu S
    PLoS One; 2017; 12(9):e0184753. PubMed ID: 28910369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed diagnosis of tuberculosis in patients with diabetes mellitus co-morbidity and its associated factors in Zhejiang Province, China.
    Xiao W; Huang D; Li S; Zhou S; Wei X; Chen B; Zou G
    BMC Infect Dis; 2021 Mar; 21(1):272. PubMed ID: 33736610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity.
    Andrade BB; Kumar NP; Sridhar R; Banurekha VV; Jawahar MS; Nutman TB; Sher A; Babu S
    Chest; 2014 Jun; 145(6):1244-1254. PubMed ID: 24458266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a More Disrupted Immune-Endocrine Relation and Cortisol Immunologic Influences in the Context of Tuberculosis and Type 2 Diabetes Comorbidity.
    Fernández RDV; Díaz A; Bongiovanni B; Gallucci G; Bértola D; Gardeñez W; Lioi S; Bertolin Y; Galliano R; Bay ML; Bottasso O; D'Attilio L
    Front Endocrinol (Lausanne); 2020; 11():126. PubMed ID: 32265833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcomes of patients with tuberculosis and diabetes: A prospective cohort study from India.
    Desai A; Gupta N; Korishetty L; Saravu K
    Int J Mycobacteriol; 2021; 10(2):111-115. PubMed ID: 34558460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.